BPG is committed to discovery and dissemination of knowledge
Citation
Paka L, Smith DE, Jung D, McCormack S, Zhou P, Duan B, Li JS, Shi J, Hao YJ, Jiang K, Yamin M, Goldberg ID, Narayan P. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. World J Gastroenterol 2017; 23(23): 4181-4190 [PMID: 28694658 DOI: 10.3748/wjg.v23.i23.4181]
Please LOGIN to submit a new comment.